24 March 2022 4 Min Read
Remgro facing investor pressure to unbundle Mediclinic
Investors argue Remgro should consider unbundling its stake in Mediclinic but CEO Jannie Durand says that's not on the cards right now
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In